Ignite Creation Date:
2025-12-18 @ 8:26 AM
Ignite Modification Date:
2025-12-18 @ 8:26 AM
Study NCT ID:
NCT07038915
Status:
None
Last Update Posted:
2025-08-05 00:00:00
First Post:
2025-06-18 00:00:00
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
STRIVE: A Single-arm Phase 2 Study on Treatment of Lung Squamous Cell Carcinoma by Tiragolumab Plus Ivonescimab for Patients Who Progressed on Platinum Doublets and Anti-PD-1/PD-L1
Sponsor:
None
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2025-0406
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
None
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None